CIK: 0001388325 · Show all filings
Period: Q3 2016 (← Previous) (Next →)
Filing Date: Nov 14, 2016
Total Value ($000): $1,125,983 (99.5% shares, 0.5% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VTI | VANGUARD INDEX FDS | 2,155,100 | $239,927 | 21.3% | $57.39 | — | TOTAL STK MKT | 922908769 |
| INGN | INOGEN INC | 3,549,320 | $212,604 | 18.9% | $17.78 | +213.4% | COM | 45780L104 |
| — | OPHTHOTECH CORP | 3,610,487 | $166,552 | 14.8% | $32.35 | — | COM | 683745103 |
| — | COLUCID PHARMACEUTICALS INC | 3,156,563 | $120,423 | 10.7% | $9.83 | — | COM | 19716T101 |
| VGK | VANGUARD INTL EQUITY INDEX F | 2,101,000 | $102,382 | 9.1% | $45.01 | — | FTSE EUROPE ETF | 922042874 |
| — | REATA PHARMACEUTICALS INC | 3,367,763 | $88,774 | 7.9% | $19.75 | — | CL A | 75615P103 |
| CRVS | CORVUS PHARMACEUTICALS INC | 3,224,046 | $53,036 | 4.7% | $14.33 | +0.6% | COM | 221015100 |
| — | ACCELERON PHARMA INC | 903,833 | $32,710 | 2.9% | $28.86 | — | COM | 00434H108 |
| — | SPECTRANETICS CORP | 1,155,722 | $28,997 | 2.6% | $18.07 | — | COM | 84760C107 |
| — | MERUS N V | 1,410,417 | $23,624 | 2.1% | $7.99 | — | COM | N5749R100 |
| — | FLEXION THERAPEUTICS INC | 1,097,718 | $21,449 | 1.9% | $15.58 | — | COM | 33938J106 |
| — | INVUITY INC | 1,285,448 | $17,636 | 1.6% | $9.68 | — | COM | 46187J205 |
| — | NABRIVA THERAPEUTICS AG | 1,116,660 | $7,872 | 0.7% | $9.04 | — | COM | 62957M104 |
| — | WRIGHT MED GROUP N V | 4,622,032 | $6,055 | 0.5% | $1.25 | — | RIGHT 03/01/2019 | N96617126 |
| — | HTG MOLECULAR DIAGNOSTICS INC | 1,280,185 | $2,906 | 0.3% | $11.15 | — | COM | 40434H104 |
| XENE | XENON PHARMACEUTICALS INC | 127,563 | $1,033 | 0.1% | $14.68 | -47.4% | COM | 98420N105 |
| OPK | OPKO HEALTH INC | 259 | $3 | 0.0% | $9.96 | 0.0% | COM | 68375N103 |